Department of Gastrointestinal Surgery, Vestfold Hospital, 3103 Tonsberg, Norway.
World J Gastroenterol. 2012 Sep 14;18(34):4714-20. doi: 10.3748/wjg.v18.i34.4714.
To study and provide data on the evolution of medical procedures and outcomes of patients suffering from perforated midgut diverticulitis.
Three data sources were used: the Medline and Google search engines were searched for case reports on one or more patients treated for perforated midgut diverticulitis (Meckel's diverticulitis excluded) that were published after 1995. The inclusion criterion was sufficient individual patient data in the article. Both indexed and non-indexed journals were used. Patients treated for perforated midgut diverticulitis at Vestfold Hospital were included in this group. Data on symptoms, laboratory and radiology results, treatment modalities, surgical access, procedures, complications and outcomes were collected. The Norwegian patient registry was searched to find patients operated upon for midgut diverticulitis from 1999 to 2007. The data collected were age, sex, mode of access, surgical procedure performed and number of patients per year. Historical controls were retrieved from an article published in 1995 containing pertinent individual patient data. Statistical analysis was done with SPSS software.
Group I: 106 patients (48 men) were found. Mean age was 72.2 ± 13.1 years (mean ± SD). Age or sex had no impact on outcomes (P = 0.057 and P = 0.771, respectively). Preoperative assessment was plain radiography in 53.3% or computed tomography (CT) in 76.1%. Correct diagnosis was made in 77.1% with CT, 5.6% without (P = 0.001). Duration of symptoms before hospitalization was 3.6 d (range: 1-35 d), but longer duration was not associated with poor outcome (P = 0.748). Eighty-six point eight percent of patients underwent surgery, 92.4% of these through open access where 90.1% had bowel resection. Complications occurred in 19.2% of patients and 16.3% underwent reoperation. Distance from perforation to Treitz ligament was 41.7 ± 28.1 cm. At surgery, no peritonitis was found in 29.7% of patients, local peritonitis in 47.5%, and diffuse peritonitis in 22.8%. Peritonitis grade correlated with the reoperation rate (r = 0.43). Conservatively treated patients had similar hospital length of stay as operated patients (10.6 ± 8.3 d vs 10.7 ± 7.9 d, respectively). Age correlated with hospital stay (r = 0.46). No difference in outcomes for operated or nonoperated patients was found (P = 0.814). Group II: 113 patients (57 men). Mean age 67.6 ± 16.4 years (range: 21-96 years). Mean age for men was 61.3 ± 16.2 years, and 74.7 ± 12.5 years for women (P = 0.001). Number of procedures per year was 11.2 ± 0.9, and bowel resection was performed in 82.3% of patients. Group III: 47 patients (21 men). Patient age was 65.4 ± 14.4 years. Mean age for men was 61.5 ± 17.3 years and 65.3 ± 14.4 years for women. Duration of symptoms before hospitalization was 6.9 d (range: 1-180 d). No patients had a preoperative diagnosis, 97.9% of patients underwent surgery, and 78.3% had multiple diverticula. Bowel resection was performed in 67.4% of patients, and suture closure in 32.6%. Mortality was 23.4%. There was no difference in length of history or its impact on survival between Groups I and III (P = 0.241 and P = 0.198, respectively). Resection was more often performed in Group I (P = 0.01). Mortality was higher in Group III (P = 0.002).
In cases with contained perforation, conservative treatment gives satisfactory results, laparoscopy with lavage and drainage can be attempted and continued with a conservative course.
研究和提供穿孔性回肠憩室炎患者手术程序和治疗结果演变的数据。
使用了三个数据源:1995 年后发表的一篇或多篇报道患有穿孔性回肠憩室炎(除外 Meckel 憩室炎)患者的病例报告,使用 Medline 和 Google 搜索引擎进行搜索。纳入标准是文章中提供了足够的个体患者数据。使用索引和非索引期刊。Vestfold 医院治疗的穿孔性回肠憩室炎患者纳入该组。收集症状、实验室和放射学结果、治疗方式、手术入路、手术程序、并发症和治疗结果等数据。检索挪威患者登记处,以查找 1999 年至 2007 年期间因回肠憩室炎接受手术的患者。收集的资料包括年龄、性别、手术入路、实施的手术程序以及每年的患者人数。从 1995 年发表的一篇包含相关个体患者数据的文章中检索历史对照。使用 SPSS 软件进行统计分析。
组 I:发现 106 例(48 例男性)患者。平均年龄为 72.2 ± 13.1 岁(均值 ± SD)。年龄或性别对治疗结果无影响(P = 0.057 和 P = 0.771)。术前评估方法为 53.3%的普通 X 线检查或 76.1%的计算机断层扫描(CT)。CT 正确诊断率为 77.1%,无 CT 检查正确诊断率为 5.6%(P = 0.001)。住院前症状持续时间为 3.6 天(范围:1-35 天),但症状持续时间较长与治疗结果不佳无关(P = 0.748)。86.8%的患者接受了手术,其中 92.4%通过开放入路进行,其中 90.1%进行了肠切除术。19.2%的患者发生了并发症,16.3%的患者进行了再次手术。穿孔至Treitz 韧带的距离为 41.7 ± 28.1cm。术中发现 29.7%的患者无腹膜炎,47.5%的患者有局限性腹膜炎,22.8%的患者有弥漫性腹膜炎。腹膜炎分级与再手术率相关(r = 0.43)。接受保守治疗的患者与接受手术治疗的患者的住院时间相似(分别为 10.6 ± 8.3 天和 10.7 ± 7.9 天)。年龄与住院时间相关(r = 0.46)。未发现手术治疗或非手术治疗患者的治疗结果存在差异(P = 0.814)。组 II:113 例(57 例男性)患者。平均年龄为 67.6 ± 16.4 岁(范围:21-96 岁)。男性平均年龄为 61.3 ± 16.2 岁,女性为 74.7 ± 12.5 岁(P = 0.001)。每年手术次数为 11.2 ± 0.9,82.3%的患者行肠切除术。组 III:47 例(21 例男性)患者。患者年龄为 65.4 ± 14.4 岁。男性平均年龄为 61.5 ± 17.3 岁,女性为 65.3 ± 14.4 岁。住院前症状持续时间为 6.9 天(范围:1-180 天)。没有患者有术前诊断,97.9%的患者接受了手术,78.3%的患者有多个憩室。67.4%的患者行肠切除术,32.6%的患者行缝合关闭术。死亡率为 23.4%。组 I 和组 III 之间的病程历史及其对生存的影响无差异(P = 0.241 和 P = 0.198)。组 I 中更常进行切除术(P = 0.01)。组 III 的死亡率更高(P = 0.002)。
在有局限穿孔的情况下,保守治疗可获得满意的结果,可以尝试腹腔镜灌洗和引流,并继续进行保守治疗。